Skip to content

Albemarle

US · ALB #1279 by market cap Listed 1970
79.70 -3.23 -3.89%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
  • Total institutional ownership fell 0.1 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
99.42% -0.14pp
Institutions
1,069 -2
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund83.03%
Public Company6.77%
Hedge Fund3.90%
Private Company2.04%
Government Pension Fund1.61%
Sovereign Wealth Fund1.36%
Family Office/Trust0.29%
Individual/Insider0.23%
Insurance Company0.18%
Other0.59%

Top holders as of 2026-09-30

BlackRock 8.50% · 10.03M sh
Capital Research 8.19% · 9.67M sh
Vanguard Capital Management, LLC 7.12% · 8.40M sh
Vanguard Portfolio Management, LLC 5.47% · 6.46M sh
State Street Global Advisors 5.36% · 6.32M sh
FMR 3.42% · 4.03M sh
Franklin Resources 2.86% · 3.37M sh
Geode Capital Management, LLC 2.66% · 3.14M sh
Barclays PLC 2.03% · 2.39M sh
PRIMECAP Management Company 2.26% · 2.67M sh
Van Eck Associates Corporation 1.91% · 2.26M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 38 buys · 12 sells

NameRoleStake
Jerry Masters Chairperson & CEO 0.07%
Eric Norris Executive Vice President 0.03%
Netha Johnson Former President of Specialties Global Business Unit 0.03%
Donald LaBauve Former Chief Accounting Officer, VP, Corporate Controller & CFO of Lithium Global Business Unit 0.02%
Alejandro Wolff Independent Director 0.01%
Mary Brlas Independent Director 0.01%
Gerald Steiner Lead Independent Director 0.01%
Dean Seavers Former Independent Director 0.01%
Diarmuid O'Connell Independent Director 0.01%
Glenda Minor Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 Neal Sheorey Chief Financial Officer Sale to Issuer -849 $99.25
2026-09-30 Alejandro Wolff Independent Director Other Acquisition +45 --
2026-09-13 Eric Norris Executive Vice President Other Acquisition +10,867 --
2026-09-13 Mark Mummert Chief Operating Officer Other Acquisition +6,086 --
2026-09-13 Autumn Gagarinas Senior VP & Chief People and Workplace Transformation Officer Other Acquisition +5,217 --
2026-08-31 Max Hood Chief Accounting Officer Other Acquisition +1,476 --
2026-07-20 Eduardo de Salles Bartolomeo Independent Director Other Acquisition +1,375 --
2026-06-30 Mary Brlas Independent Director Other Acquisition +36 --
2026-06-30 Mary Brlas Independent Director Other Acquisition +1,250 --
2026-06-30 Gerald Steiner Lead Independent Director Other Acquisition +36 --
2026-06-30 Gerald Steiner Lead Independent Director Other Acquisition +1,250 --
2026-06-30 Glenda Minor Independent Director Other Derivative Acquisition +1,250 --
2026-06-30 Mark Widmar Independent Director Other Derivative Acquisition +1,250 --
2026-06-30 Holly Van Deursen Independent Director Other Derivative Acquisition +1,250 --
2026-06-30 Ralf Cramer Independent Director Sale to Issuer -942 $136.08
2026-06-30 Ralf Cramer Independent Director Other Acquisition +36 --
2026-06-30 Ralf Cramer Independent Director Other Acquisition +1,250 --
2026-06-30 Diarmuid O'Connell Independent Director Other Acquisition +36 --
2026-06-30 Diarmuid O'Connell Independent Director Other Acquisition +1,250 --
2026-06-30 Alejandro Wolff Independent Director Other Acquisition +33 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.

Albemarle discussion 0 comments

Add a comment